Related Experiment Videos

High-dose statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis

Bu-Chun Zhang1, Wei-Ming Li, Ya-Wei Xu

  • 1Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

Insights

Short-term high-dose statin pretreatment effectively reduces contrast-induced nephropathy (CIN) and serum creatinine levels in patients undergoing contrast procedures. However, it does not benefit those with pre-existing renal impairment.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • Contrast-induced nephropathy (CIN) is a significant complication of contrast-based medical procedures.
  • Statins are investigated for CIN prevention, but clinical outcomes have been inconsistent.
  • Understanding optimal statin use for CIN prevention is crucial for patient care.

Purpose of the Study:

  • To evaluate the efficacy of short-term, high-dose statin administration versus conventional doses or placebo in preventing CIN.
  • To assess the impact of statin pretreatment on serum creatinine levels post-procedure.
  • To determine if statin effectiveness varies in patients with pre-existing renal impairment.

Main Methods:

  • A meta-analysis of 8 randomized clinical trials involving 1423 patients.
  • Pooled analysis of data to compare short-term high-dose statin therapy with control groups.
  • Subgroup analysis to assess outcomes in patients with pre-existing renal impairment.

Main Results:

  • Short-term high-dose statin treatment significantly decreased CIN occurrence (RR 0.51, P=0.001).
  • High-dose statins also reduced 48-hour serum creatinine levels (SMD -0.07 mg/dL, P<0.00001).
  • No significant reduction in CIN was observed in patients with pre-existing renal impairment (RR 0.90, P=0.73).

Conclusions:

  • Short-term high-dose statin pretreatment is effective in reducing CIN and serum creatinine levels in patients undergoing contrast procedures.
  • Statin pretreatment did not show benefit for CIN prevention in patients with pre-existing renal impairment.
  • Further prospective trials are recommended to confirm these findings and establish definitive conclusions.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...